サマリー

胃がん治療薬の世界市場 2023-2027
胃がん治療薬市場は、2022-2027年に1億2764.91万米ドルの成長が予測され、予測期間中のCAGRは14.85%で加速すると予測されます。当レポートでは、胃がん治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。胃がんに対する啓蒙活動の増加、高齢者人口の増加、胃がんの有病率の増加などが市場を牽引しています。
Technavio社の胃がん治療薬市場は以下のように分類されます：
投与経路別
- 注射剤
- 経口剤
流通チャネル別
- オフライン
- オンライン
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間における胃がん治療薬市場の成長を促進する主な要因の1つとして、医薬品の承認数や上市数の増加を挙げている。また、胃がん治療薬の強力なパイプラインとベンダーによる研究開発の増加は、市場の大きな需要につながる。
本レポートでは、胃がん治療薬市場について以下の領域をカバーしています：
- 胃がん治療薬市場のサイジング
- 胃がん治療薬市場予測
- 胃がん治療薬市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、アボットラボラトリーズ、AbbVie Inc.、AROG Pharmaceuticals INC.、AstraZeneca Plc、Bayer AG、Biocon Ltd.、Blueprint Medicines Corp.、Boehringer Ingelheim International GmbH、Bristol Myers Squibb Co.、Celltrion Co.Ltd.、Dr. Reddys Laboratories Ltd.、エーザイ株式会社、Eli Lilly and Co.Ltd.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、Merck KGaA、Novartis AG、Samsung Biologics Co.武田薬品工業株式会社Ltd.、ザイダスライフサイエンス（株）、大塚ホールディングス（株）。Ltd.である。また、胃癌治療薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gastric-cancer-drugs-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global gastric cancer drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global gastric cancer drugs market 2017 - 2021 ($ million)
o 4.2 Route of Administration Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Injectable - Market size and forecast 2022-2027
o Exhibit 34: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Injectable - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
o 6.4 Oral - Market size and forecast 2022-2027
o Exhibit 38: Chart on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Oral - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Oral - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Route of Administration
o Exhibit 42: Market opportunity by Route of Administration ($ million)
o Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline - Market size and forecast 2022-2027
o Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 7.4 Online - Market size and forecast 2022-2027
o Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ million)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share by geography 2022-2027 (%)
o Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 99: Market opportunity by geography ($ million)
o Exhibit 100: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories - Overview
o Exhibit 108: Abbott Laboratories - Business segments
o Exhibit 109: Abbott Laboratories - Key news
o Exhibit 110: Abbott Laboratories - Key offerings
o Exhibit 111: Abbott Laboratories - Segment focus
o 12.4 AROG Pharmaceuticals INC.
o Exhibit 112: AROG Pharmaceuticals INC. - Overview
o Exhibit 113: AROG Pharmaceuticals INC. - Product / Service
o Exhibit 114: AROG Pharmaceuticals INC. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 115: AstraZeneca Plc - Overview
o Exhibit 116: AstraZeneca Plc - Product / Service
o Exhibit 117: AstraZeneca Plc - Key news
o Exhibit 118: AstraZeneca Plc - Key offerings
o 12.6 Bayer AG
o Exhibit 119: Bayer AG - Overview
o Exhibit 120: Bayer AG - Business segments
o Exhibit 121: Bayer AG - Key news
o Exhibit 122: Bayer AG - Key offerings
o Exhibit 123: Bayer AG - Segment focus
o 12.7 Biocon Ltd.
o Exhibit 124: Biocon Ltd. - Overview
o Exhibit 125: Biocon Ltd. - Business segments
o Exhibit 126: Biocon Ltd. - Key offerings
o Exhibit 127: Biocon Ltd. - Segment focus
o 12.8 Boehringer Ingelheim International GmbH
o Exhibit 128: Boehringer Ingelheim International GmbH - Overview
o Exhibit 129: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 130: Boehringer Ingelheim International GmbH - Key news
o Exhibit 131: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 132: Boehringer Ingelheim International GmbH - Segment focus
o 12.9 Bristol Myers Squibb Co.
o Exhibit 133: Bristol Myers Squibb Co. - Overview
o Exhibit 134: Bristol Myers Squibb Co. - Product / Service
o Exhibit 135: Bristol Myers Squibb Co. - Key news
o Exhibit 136: Bristol Myers Squibb Co. - Key offerings
o 12.10 Celltrion Co. Ltd.
o Exhibit 137: Celltrion Co. Ltd. - Overview
o Exhibit 138: Celltrion Co. Ltd. - Product / Service
o Exhibit 139: Celltrion Co. Ltd. - Key offerings
o 12.11 Dr Reddys Laboratories Ltd.
o Exhibit 140: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 141: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 142: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 143: Dr Reddys Laboratories Ltd. - Segment focus
o 12.12 Eisai Co. Ltd.
o Exhibit 144: Eisai Co. Ltd. - Overview
o Exhibit 145: Eisai Co. Ltd. - Business segments
o Exhibit 146: Eisai Co. Ltd. - Key offerings
o Exhibit 147: Eisai Co. Ltd. - Segment focus
o 12.13 Eli Lilly and Co.
o Exhibit 148: Eli Lilly and Co. - Overview
o Exhibit 149: Eli Lilly and Co. - Product / Service
o Exhibit 150: Eli Lilly and Co. - Key news
o Exhibit 151: Eli Lilly and Co. - Key offerings
o 12.14 F. Hoffmann La Roche Ltd.
o Exhibit 152: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 153: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 154: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 155: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 156: F. Hoffmann La Roche Ltd. - Segment focus
o 12.15 Merck KGaA
o Exhibit 157: Merck KGaA - Overview
o Exhibit 158: Merck KGaA - Business segments
o Exhibit 159: Merck KGaA - Key news
o Exhibit 160: Merck KGaA - Key offerings
o Exhibit 161: Merck KGaA - Segment focus
o 12.16 Novartis AG
o Exhibit 162: Novartis AG - Overview
o Exhibit 163: Novartis AG - Business segments
o Exhibit 164: Novartis AG - Key offerings
o Exhibit 165: Novartis AG - Segment focus
o 12.17 Samsung Biologics Co. Ltd.
o Exhibit 166: Samsung Biologics Co. Ltd. - Overview
o Exhibit 167: Samsung Biologics Co. Ltd. - Product / Service
o Exhibit 168: Samsung Biologics Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global gastric cancer drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Injectable - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share by geography 2022-2027 (%)
Exhibits60: Data Table on Market share by geography 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity by geography ($ million)
Exhibits100: Data Tables on Market opportunity by geography ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories - Overview
Exhibits108: Abbott Laboratories - Business segments
Exhibits109: Abbott Laboratories - Key news
Exhibits110: Abbott Laboratories - Key offerings
Exhibits111: Abbott Laboratories - Segment focus
Exhibits112: AROG Pharmaceuticals INC. - Overview
Exhibits113: AROG Pharmaceuticals INC. - Product / Service
Exhibits114: AROG Pharmaceuticals INC. - Key offerings
Exhibits115: AstraZeneca Plc - Overview
Exhibits116: AstraZeneca Plc - Product / Service
Exhibits117: AstraZeneca Plc - Key news
Exhibits118: AstraZeneca Plc - Key offerings
Exhibits119: Bayer AG - Overview
Exhibits120: Bayer AG - Business segments
Exhibits121: Bayer AG - Key news
Exhibits122: Bayer AG - Key offerings
Exhibits123: Bayer AG - Segment focus
Exhibits124: Biocon Ltd. - Overview
Exhibits125: Biocon Ltd. - Business segments
Exhibits126: Biocon Ltd. - Key offerings
Exhibits127: Biocon Ltd. - Segment focus
Exhibits128: Boehringer Ingelheim International GmbH - Overview
Exhibits129: Boehringer Ingelheim International GmbH - Business segments
Exhibits130: Boehringer Ingelheim International GmbH - Key news
Exhibits131: Boehringer Ingelheim International GmbH - Key offerings
Exhibits132: Boehringer Ingelheim International GmbH - Segment focus
Exhibits133: Bristol Myers Squibb Co. - Overview
Exhibits134: Bristol Myers Squibb Co. - Product / Service
Exhibits135: Bristol Myers Squibb Co. - Key news
Exhibits136: Bristol Myers Squibb Co. - Key offerings
Exhibits137: Celltrion Co. Ltd. - Overview
Exhibits138: Celltrion Co. Ltd. - Product / Service
Exhibits139: Celltrion Co. Ltd. - Key offerings
Exhibits140: Dr Reddys Laboratories Ltd. - Overview
Exhibits141: Dr Reddys Laboratories Ltd. - Business segments
Exhibits142: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits143: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits144: Eisai Co. Ltd. - Overview
Exhibits145: Eisai Co. Ltd. - Business segments
Exhibits146: Eisai Co. Ltd. - Key offerings
Exhibits147: Eisai Co. Ltd. - Segment focus
Exhibits148: Eli Lilly and Co. - Overview
Exhibits149: Eli Lilly and Co. - Product / Service
Exhibits150: Eli Lilly and Co. - Key news
Exhibits151: Eli Lilly and Co. - Key offerings
Exhibits152: F. Hoffmann La Roche Ltd. - Overview
Exhibits153: F. Hoffmann La Roche Ltd. - Business segments
Exhibits154: F. Hoffmann La Roche Ltd. - Key news
Exhibits155: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits156: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits157: Merck KGaA - Overview
Exhibits158: Merck KGaA - Business segments
Exhibits159: Merck KGaA - Key news
Exhibits160: Merck KGaA - Key offerings
Exhibits161: Merck KGaA - Segment focus
Exhibits162: Novartis AG - Overview
Exhibits163: Novartis AG - Business segments
Exhibits164: Novartis AG - Key offerings
Exhibits165: Novartis AG - Segment focus
Exhibits166: Samsung Biologics Co. Ltd. - Overview
Exhibits167: Samsung Biologics Co. Ltd. - Product / Service
Exhibits168: Samsung Biologics Co. Ltd. - Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations